Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

Robin E. Norris; Elizabeth Fox; Joel M. Reid; Andrew Ralya; Xiaowei W. Liu; Charles Minard; Brenda J. Weigel

doi:10.1002/pbc.26944

Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

Pediatric Blood & Cancer ◽

10.1002/pbc.26944 ◽

2018 ◽

Vol 65 (5) ◽

pp. e26944 ◽

Cited By ~ 8

Author(s):

Robin E. Norris ◽

Elizabeth Fox ◽

Joel M. Reid ◽

Andrew Ralya ◽

Xiaowei W. Liu ◽

...

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Oncology Group ◽

Phase 1 Trial

Download Full-text

Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study

Pediatric Blood & Cancer ◽

10.1002/pbc.24874 ◽

2013 ◽

Vol 61 (5) ◽

pp. 833-839 ◽

Cited By ~ 55

Author(s):

Rochelle Bagatell ◽

Robin Norris ◽

Ashish M. Ingle ◽

Charlotte Ahern ◽

Stephan Voss ◽

...

Keyword(s):

Young Adults ◽

Solid Tumors ◽

Phase 1 ◽

Adolescents And Young Adults ◽

Oncology Group ◽

Oncology Group Study ◽

Phase 1 Trial

Download Full-text

Faculty of 1000 evaluation for Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718181537.793487656 ◽

2013 ◽

Author(s):

Daniel Indelicato

Keyword(s):

Young Adults ◽

Solid Tumors ◽

Phase 1 ◽

Adolescents And Young Adults ◽

Oncology Group ◽

Oncology Group Study ◽

Phase 1 Trial

Download Full-text

Faculty Opinions recommendation of A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733109543.793558288 ◽

2019 ◽

Author(s):

Stephen Lessnick

Keyword(s):

Children And Adolescents ◽

Solid Tumors ◽

Phase 1 ◽

Cns Tumors ◽

Oncology Group ◽

Phase 1 Study

Download Full-text

A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)

British Journal of Haematology ◽

10.1111/bjh.14569 ◽

2017 ◽

Vol 177 (3) ◽

pp. 467-474 ◽

Cited By ~ 14

Author(s):

Susan R. Rheingold ◽

Sarah K. Tasian ◽

James A. Whitlock ◽

David T. Teachey ◽

Michael J. Borowitz ◽

...

Keyword(s):

Acute Lymphoblastic Leukaemia ◽

Induction Chemotherapy ◽

Lymphoblastic Leukaemia ◽

Phase 1 ◽

Oncology Group ◽

Oncology Group Study ◽

Phase 1 Trial

Download Full-text

Phase 1 trial of Anvirzel™ in patients with refractory solid tumors

Investigational New Drugs ◽

10.1007/s10637-006-7772-x ◽

2006 ◽

Vol 24 (5) ◽

pp. 423-427 ◽

Cited By ~ 51

Author(s):

Tarek Mekhail ◽

Hanspreet Kaur ◽

Ram Ganapathi ◽

G. Thomas Budd ◽

Paul Elson ◽

...

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Phase 1 Trial

Download Full-text

Abstract A092: Phase 1 trial of RO6874813, a novel bispecific FAP-DR5 antibody, in patients with solid tumors

10.1158/1535-7163.targ-17-a092 ◽

2018 ◽

Cited By ~ 3

Author(s):

Johanna Bendell ◽

Jean-Yves Blay ◽

Philippe Cassier ◽

Todd Bauer ◽

Catherine Terret ◽

...

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Phase 1 Trial

Download Full-text

Abstract CT012: Phase 1 trial of first-in-class ATR inhibitor VX-970 in combination with cisplatin (Cis) in patients (pts) with advanced solid tumors (NCT02157792)

10.1158/1538-7445.am2016-ct012 ◽

2016 ◽

Cited By ~ 5

Author(s):

Geoffrey Shapiro ◽

Robert Wesolowski ◽

Mark Middleton ◽

Craig Devoe ◽

Anastasia Constantinidou ◽

...

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Phase 1 Trial

Download Full-text

Abstract PD4-02: Canadian cancer trials group trial IND.231: A phase 1 trial evaluating CX-5461, a novel first-in-class G-quadruplex stabilizer in patients with advanced solid tumors enriched for DNA-repair deficiencies

10.1158/1538-7445.sabcs19-pd4-02 ◽

2020 ◽

Author(s):

John Hilton ◽

Karen Gelmon ◽

David Cescon ◽

Anna Tinker ◽

Derek Jonker ◽

...

Keyword(s):

Dna Repair ◽

Solid Tumors ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Phase 1 Trial ◽

G Quadruplex ◽

Cancer Trials ◽

Group Trial

Download Full-text

Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors

Cancer ◽

10.1002/cncr.28701 ◽

2014 ◽

Vol 120 (14) ◽

pp. 2164-2173 ◽

Cited By ~ 17

Author(s):

David S. Hong ◽

Ignacio Garrido-Laguna ◽

Suhendan Ekmekcioglu ◽

Gerald S. Falchook ◽

Aung Naing ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Solid Tumors ◽

Phase 1 ◽

Vascular Endothelial ◽

Advanced Solid Tumors ◽

Phase 1 Trial ◽

Dual Inhibition ◽

Endothelial Growth Factor

Download Full-text

Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events

Cancers ◽

10.3390/cancers9070073 ◽

2017 ◽

Vol 9 (12) ◽

pp. 73 ◽

Cited By ~ 5

Author(s):

Sidra Anwar ◽

Wei Tan ◽

Chi-Chen Hong ◽

Sonal Admane ◽

Askia Dozier ◽

...

Keyword(s):

Quality Of Life ◽

Adverse Events ◽

Solid Tumors ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Serious Adverse Events ◽

Phase 1 Trial

Download Full-text